Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$9.04 - $11.75 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024

BUY
$11.43 - $14.24 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024

BUY
$9.97 - $14.52 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023

BUY
$11.78 - $13.86 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023

BUY
$10.72 - $13.3 $0 - $0
0 New
0 $0
Q1 2023

Jan 10, 2025

BUY
$10.91 - $13.54 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023

BUY
$10.91 - $13.54 $0 - $0
0 New
0 $0
Q4 2022

Jan 10, 2025

BUY
$9.89 - $12.7 $0 - $0
0 New
0 $0
Q4 2022

Feb 14, 2023

BUY
$9.89 - $12.7 $0 - $0
0 New
0 $0
Q3 2022

Jan 10, 2025

BUY
$9.82 - $12.75 $0 - $0
0 New
0 $0
Q3 2022

Nov 14, 2022

BUY
$9.82 - $12.75 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022

BUY
$9.82 - $12.75 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022

BUY
$9.82 - $12.75 $0 - $0
0 New
0 $0
Q1 2021

May 14, 2021

SELL
$9.2 - $23.86 $0 - $0
0 Closed
0 $0
Q4 2020

Jan 10, 2025

BUY
$13.47 - $24.89 $0 - $0
0 New
0 $0
Q4 2020

Feb 12, 2021

BUY
$13.47 - $24.89 $0 - $0
0 New
0 $0
Q3 2020

Nov 12, 2020

BUY
$12.89 - $15.89 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020

BUY
$8.86 - $15.69 $0 - $0
0 New
0 $0
Q1 2020

May 14, 2020

BUY
$6.63 - $11.16 $0 - $0
0 New
0 $0
Q4 2019

Feb 13, 2020

BUY
$7.48 - $10.75 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019

BUY
$8.02 - $13.25 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019

BUY
$10.96 - $14.4 $0 - $0
0 New
0 $0
Q1 2019

May 10, 2019

BUY
$10.04 - $13.92 $0 - $0
0 New
0 $0
Q1 2019

May 10, 2019

BUY
$10.04 - $13.92 $0 - $0
0 New
0 $0
Q4 2018

Feb 12, 2019

BUY
$8.38 - $13.44 $0 - $0
0 New
0 $0
Q3 2018

Nov 07, 2018

BUY
$11.6 - $16.54 $0 - $0
0 New
0 $0
Q2 2018

Aug 03, 2018

BUY
$13.13 - $17.09 $0 - $0
0 New
0 $0
Q1 2018

May 14, 2018

BUY
$13.76 - $17.12 $0 - $0
0 New
0 $0

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.58B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.